Cargando…
Novel MicroRNA Biomarkers for Colorectal Cancer Early Diagnosis and 5-Fluorouracil Chemotherapy Resistance but Not Prognosis: A Study from Databases to AI-Assisted Verifications
Colorectal cancer (CRC) is one of the major causes of cancer death worldwide. In general, early diagnosis for CRC and individual therapy have led to better survival for the cancer patients. Accumulating studies concerning biomarkers have provided positive evidence to improve cancer early diagnosis a...
Autores principales: | Zhang, Xueli, Zhang, Hong, Shen, Bairong, Sun, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073235/ https://www.ncbi.nlm.nih.gov/pubmed/32028703 http://dx.doi.org/10.3390/cancers12020341 |
Ejemplares similares
-
Potential Applications of DNA, RNA and Protein Biomarkers in Diagnosis, Therapy and Prognosis for Colorectal Cancer: A Study from Databases to AI-Assisted Verification
por: Zhang, Xueli, et al.
Publicado: (2019) -
CBD: a biomarker database for colorectal cancer
por: Zhang, Xueli, et al.
Publicado: (2018) -
CRC-EBD: Epigenetic Biomarker Database for Colorectal Cancer
por: Liu, Xingyun, et al.
Publicado: (2020) -
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis
por: Chen, Bing, et al.
Publicado: (2019) -
Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
por: Zhu, Yaqun, et al.
Publicado: (2016)